The present disclosure relates to phenyl urea derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor (FPR), such as agonism of the FPR1 and/or FPR2 receptor, or selective agonism of the FPR1 receptor relative to the FPR2 receptor.
本公开涉及苯基
脲衍
生物,制备它们的方法,含有它们的制药组合物以及它们作为药物的用途,作为N-甲酰肽受体(FPR)的调节剂,例如FPR1和/或FPR2受体的激动作用,或相对于FPR2受体的FPR1受体的选择性激动作用。